Jette Ford
Perth, WA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia.
Journal: Haematologica
Published: September 13, 2023
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.
Journal: Leukemia
Published: April 30, 2022
Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia.
Journal: Frontiers in oncology
Published: November 20, 2020
Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia.
Journal: Haematologica
Published: January 26, 2019
New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment.
Journal: Leukemia
Published: January 14, 2018
Connective tissue growth factor is expressed in bone marrow stromal cells and promotes interleukin-7-dependent B lymphopoiesis.
Journal: Haematologica
Published: April 15, 2014
Molecular characterization of identical, novel MLL-EPS15 translocation and individual genomic copy number alterations in monozygotic infant twins with acute lymphoblastic leukemia.
Journal: Haematologica
Published: May 15, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026